- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01900236
Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV (iENGAGE)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The Centers for Disease Control's Retention In Care (CDC RIC) and the Participating and Communicating Together (PACT) antiretroviral therapy (ART) adherence interventions have shown success in the literature, and they are well suited to target the two essential HIV adherence behaviors needed to achieve better overall health: HIV medical visit adherence and ART adherence. While these original interventions target each of these behaviors separately, the comprehensive iENGAGE intervention combines these two approaches to address the experience of an individual who is initiating HIV care. Upon entry to care, knowledge, motivation, and skills for adherence to HIV medical visits and ART must be learned rapidly. Jointly targeting these behaviors offers a distinct advantage over addressing them separately.
iENGAGE integrates CDC RIC and PACT through their common intervention targets with the assistance of trained interventionists, who will maintain contact with the new patient to educate and assist with reinforcing the importance of adherence to care. While the actions required to attend HIV medical care appointments and take medications properly are distinct, each is influenced by an individual's personal motivation and skills for self-management of HIV infection and overall health; these principles are the focus of the intervention sessions for this protocol .
During this intervention, our team will make every effort to protect all participants' confidential and private information in order to minimize possible study-associated risks. In addition, the follow up measurement plan for this study is unique, as it aims to utilize the X060831001: Unsolicited R24 for the Centers for AIDS Research (CFAR) Network of Integrated Clinical Sciences, (CNICS), PI Michael Saag) secure electronic data infrastructure, which has existing defined protocols for the protection of human subjects data, including a data management core that is housed at the collaborating site at the University of Washington.
Stigma Supplement (Michael J. Mugavero, Janet M. Turan, Bulent Turan)
As part of this supplement, the research team has incorporated multi-item questionnaire measures of stigma into baseline and final data collection for the iENGAGE trial. The goal of Aim 1 is to examine the longitudinal associations and potential causal mechanisms in the relationships between dimensions of HIV-related stigma and HIV visit adherence, antiretroviral therapy (ART) adherence, and viral load suppression, among control participants in the study. In addition, in Aim 2, we will examine the effects of the iENGAGE intervention on dimensions of stigma, by comparing changes in stigma in the two arms of the Randomized Controlled Trial (RCT).
For Aim 3, after participants have completed the 48-week iENGAGE intervention, we will conduct up to 40 individual in-depth face-to-face qualitative interviews with selected participants using a separate informed consent process. Topics to be explored in these interviews include qualitative exploration of how HIV-related stigma and other intersectional stigmas affect engagement in HIV care, as wells as exploring how participation in the iENGAGE intervention may have influenced the participant's experiences of anticipated, internalized, and experienced stigma; as well as disclosure concerns and actual disclosure behavior.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Alabama
-
Birmingham, Alabama, Förenta staterna, 35294
- University of Alabama at Birmingham
-
-
Maryland
-
Baltimore, Maryland, Förenta staterna, 21205
- The Johns Hopkins HIV Care Program
-
-
North Carolina
-
Chapel Hill, North Carolina, Förenta staterna, 27599
- UNC Infectious Diseases Clinic
-
-
Washington
-
Seattle, Washington, Förenta staterna, 98104
- University of Washington
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Documented HIV infection
- Newly establishing HIV care at study site
- Age 18 years or older
- English speaking
Exclusion Criteria:
- Not willing or able to provide informed consent
- Received prior outpatient HIV care
- Completed >1 primary care visits
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Inget ingripande: Control
Control arm participants will receive standard clinical care (i.e.
receive usual clinic treatment)
|
|
Experimentell: Motivation Behavioral Technique
Behavioral: 4 sessions of tailored, interactive agenda based on behavioral motivational interviewing (MI) techniques.
Each iENGAGE intervention session includes: interventionist-delivered educational content for managing HIV medical care appointment-keeping and information sessions for learning to manage HIV medications.
The goal of this intervention is for the participant to establish early behaviors that help him/her to arrive at scheduled medical appointments and learn to take medications as prescribed during the initial year of HIV care in order in order to achieve viral suppression and improve overall health.
|
In addition to receiving standard clinic care, the intervention will have a tailored, interactive agenda for each of the 4 sessions based on behavioral motivational interviewing (MI) technique.
The goal of this intervention is for the participant to establish early behaviors that help him/her to arrive at scheduled medical appointments and learn to take medications as prescribed during the initial year of HIV care in order to in order to achieve viral suppression and improve overall health.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Viral load (VL) suppression (<200c/ml) among patients newly initiating outpatient HIV medical care
Tidsram: 48 weeks
|
VL suppression is defined as <200 copies/ml of blood
|
48 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Viremia Copy Years (VCY)
Tidsram: 96 weeks
|
VCY is the area under the curve estimate of cumulative VL burden
|
96 weeks
|
Visit adherence
Tidsram: First provider visit to 48 weeks and 96 weeks
|
We will calculate visit adherence as a proportion that captures the number of "attended" visits in the numerator and the number of total scheduled visits ("attended" plus "no show") in the denominator during study period.
|
First provider visit to 48 weeks and 96 weeks
|
4 month visit constancy
Tidsram: First provider visit to 48 weeks and 96 weeks
|
We will evaluate visit constancy as the proportion of pre-specified time intervals with at least 1 attended clinic visit during the study period.
We will use 4 month time interval
|
First provider visit to 48 weeks and 96 weeks
|
Time to viral load (VL) suppression
Tidsram: First provider visit to first VL suppression with administrative censoring at 12 months
|
We will calculate time to VL suppression (defined as <200 copies/ml) as the time in days from the first medical provider visit to the first date with VL suppression.
Kaplan-Meier analyses and Cox proportional hazards analyses will be used to generate survival curves and to estimate the median time to VL suppression.
|
First provider visit to first VL suppression with administrative censoring at 12 months
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Michael J Mugavero, MD, University of Alabama at Birmingham
Publikationer och användbara länkar
Allmänna publikationer
- Yigit I, Modi RA, Weiser SD, Johnson MO, Mugavero MJ, Turan JM, Turan B. Effects of an intervention on internalized HIV-related stigma for individuals newly entering HIV care. AIDS. 2020 Sep 1;34 Suppl 1(Suppl 1):S73-S82. doi: 10.1097/QAD.0000000000002566.
- Shaw S, Modi R, Mugavero M, Golin C, Quinlivan EB, Smith LR, Roytburd K, Crane H, Keruly J, Zinski A, Amico KR. HIV Standard of Care for ART Adherence and Retention in Care Among HIV Medical Care Providers Across Four CNICS Clinics in the US. AIDS Behav. 2019 Apr;23(4):947-956. doi: 10.1007/s10461-018-2320-1.
- Modi RA, Mugavero MJ, Amico RK, Keruly J, Quinlivan EB, Crane HM, Guzman A, Zinski A, Montue S, Roytburd K, Church A, Willig JH. A Web-Based Data Collection Platform for Multisite Randomized Behavioral Intervention Trials: Development, Key Software Features, and Results of a User Survey. JMIR Res Protoc. 2017 Jun 16;6(6):e115. doi: 10.2196/resprot.6768.
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 1R01AI103661 (U.S.S. NIH-anslag/kontrakt)
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på HIV
-
University of Alabama at BirminghamMobile County Health Deparment; Alabama Department of Public HealthRekryteringHIV | HIV-testning | HIV-koppling till vård | HIV-behandlingFörenta staterna
-
ANRS, Emerging Infectious DiseasesHopital Universitaire Robert-Debre; Institut de Recherche pour le Developpement och andra samarbetspartnersOkändHIV | HIV-oinfekterade barn | Barn som utsätts för HIVKamerun
-
CDC FoundationGilead SciencesOkändHIV Preexponeringsprofylax | HIV KemoprofylaxFörenta staterna
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS FoundationAvslutadPartners HIV-testning | Hiv-rådgivning för par | Par kommunikation | Hiv-incidensKamerun, Dominikanska republiken, Georgien, Indien
-
University of MinnesotaIndragenHIV-infektioner | HIV/AIDS | Hiv | AIDS | Aids/Hiv problem | AIDS och infektionerFörenta staterna
-
Hospital Clinic of BarcelonaAvslutadIntegrashämmare, HIV; HIV PROTEAS HÄMMARSpanien
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London och andra samarbetspartnersRekryteringHIV | HIV-testning | Koppling till vårdSydafrika
-
University of WashingtonNational Institute of Mental Health (NIMH)RekryteringHIV-förebyggande | HIV Preexponeringsprofylax | GenomförandeKenya
-
University of Maryland, BaltimoreIndragenHiv | Njurtransplantation | HIV-reservoar | CCR5Förenta staterna
-
Erasmus Medical CenterHar inte rekryterat ännuHIV-infektioner | Hiv | HIV-1-infektion | HIV I-infektionNederländerna
Kliniska prövningar på Based on behavioral motivational interviewing (MI) technique
-
The University of Hong Kong-Shenzhen HospitalAvslutad